Of note however, the FEM modules clustered most closely with a cluster of biological pathways which included proliferation, B-MYB activation, p53 mutation, PIK3CA activation and stemness, supporting their association with a highly proliferative and poor-outcome ER+ breast cancer (Fig. 5). Here, ESR1 is linked to breast carcinoma.